|
⚲
|
| Keyboard |
| Mitchell Mutz | |
|---|---|
| Firm | |
| Address | 181 2nd Street San Francisco, CA 94105 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Omniox Inc | 021-578310 | Director | 24.1 M of 28.1 M |
||
| Epibiologics Inc | 021-480390 | Executive Officer | 73.0 M of 73.0 M |
||
| Bonum Therapeutics Inc | 021-465970 | Director | 45.0 M of 93.0 M |
||
| Pandion Therapeutics HoldCo LLC | 021-364484 | Director | 40.0 M of 80.0 M |
||
| Good Therapeutics Inc | 021-326349 | Director | 22.3 M of 22.3 M |
||
| Pandion Therapeutics Inc | 021-303791 | Director | 21.6 M of 57.6 M |
||
| Purigen Biosystems Inc | 021-259041 | Director | 26.4 M of 30.8 M |
||
| Amplyx Pharmaceuticals Inc | 021-251044 | Executive Officer | 23.7 M of 49.2 M |
||
| Amplyx Pharmaceuticals Inc | 021-246005 | Executive Officer | 1.5 M of 1.5 M |
||